SYN818

SYN818 · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SYN818, covering 2025-07-20 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1]